Tech Company Financing Transactions
NexGenix Pharmaceuticals Funding Round
NexGenix Pharmaceuticals, operating out of New York, secured $3.9 million in funding from private investors.
Transaction Overview
Company Name
Announced On
7/16/2007
Transaction Type
Venture Equity
Amount
$3,900,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
30 East 85th St. 3B
New York, NY 10028
USA
New York, NY 10028
USA
Phone
Website
Email Address
Overview
NexGenix Pharmaceuticals is a US-based company focused on drug development for Neurofibromatosis Types 1 and 2 and related sporadic tumors. Neurofibromatosis (NF) is an autosomal dominant genetic disorder characterized by the development of tumors along nerves.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Allan Rubenstein
VP - R & D
Ruihong Chen
Browse more venture capital transactions:
Prev: 7/16/2007: MyShape venture capital transaction
Next: 7/16/2007: Arkeia Software venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs